Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT07474376
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Fabla Mobile App — OTHERParticipants will use an adapted audio diary mobile application (Fabla-diabetesMM) designed to collect daily structured and semi-structured audio reflections on health conditions, symptoms, self-management strategies, goal attainment, and feasibility feedback. The app is tailored for older adults, including adjustments to interface, font, navigation, and question wording. Intervention Components: * Daily audio diary entries for 7 days, with optional continued use up to 1 or 3 months * Structured survey items integrated into the app (e.g., symptoms, self-regulation, self-efficacy, healthcare use) * Semi-structured audio prompts about daily experiences, self-management, and health changes * Reminder notifications to encourage diary completion * Video instructions on how to use the app
Study Details
The goal of this clinical trial is to evaluate whether an audio diary mobile application (Fabla-diabetesMM) is feasible to use and may support self-management in older adults with type 1 or 2 diabetes and multimorbidity. The main questions it aims to answer are: * Is it feasible to adapt and implement the Fabla-diabetesMM audio diary mobile app among 30 older adults with diabetes and multimorbidity * Does the use of the audio diary mobile app affect self-management outcomes
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Single-Arm Feasibility InterventionParticipants are older adults (≥65 years) with type 1 or type 2 diabetes and at least one comorbidity. All participants receive the adapted Fabla-diabetesMM audio diary mobile application and complete structured surveys and audio diary entries over 7 days and up to 1-3 months.
Primary Outcome Measure
Feasibility of the Audio Diary Mobile App [ Time Frame: Day 1-7; Day 7-1 or 3 months ]
Central Contacts
- Wenhui Zhang, PhD762-499-0411
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory Healthcare | Atlanta | Georgia | 30329 |
Find similar trials in Atlanta, GA
By condition
By specialty
By research site
Related Studies
- TrialNet Pathway to Prevention of T1DRecruiting · University of South Florida · Orange, California
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsRecruiting · Cleerly, Inc. · Chandler, Arizona
- Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPHASE3 · Recruiting · vTv Therapeutics · Scottsdale, Arizona
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePHASE3 · Recruiting · Boehringer Ingelheim · Anniston, Alabama